Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680719 · ClinicalTrials.gov registry record · Phase 1
Preventing HIV/Aids in Drug Abusing Youth
A Phase 1 study of HIV Infections, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT00680719 is a Phase 1 study of HIV Infections that has completed, run by Oregon Research Institute. The registered enrollment target is 111 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00680719, a Phase 1 study of HIV Infections, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
This project involves two studies focusing on the engagement and treatment of adolescents diagnosed with substance use disorders. Study 1 will evaluate a promising parent-based engagement intervention, Community Reinforcement Training, designed to facilitate the entry of resistant drug-abusing adolescents in treatment. The approach will be compared with an Engagement As Usual intervention condition. Study 2 involves a controlled clinical trial evaluating the efficacy of an HIV/AIDS prevention intervention embedded in family-based drug abuse treatment for reducing HIV/AIDS risk behaviors and substance use. Adolescents who are successfully engaged in treatment through Study 1 will be randomly assigned to receive either family therapy alone or family therapy with the integrated HIV/AIDS prevention intervention. Both studies are being conducted in Portland, Oregon.
Conditions Studied
Interventions
- BEHAVIORAL IBFT /HIV prevention
- BEHAVIORAL IBFT
Study Locations (1)
Oregon
- Oregon Research Institute Center for Family and Adolescent Research - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2004-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680719
The ClinicalTrials.gov registry entry for NCT00680719 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (75% lower). The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which IBFT /HIV prevention is the first listed.
NCT00680719 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT00680719 about?
NCT00680719 is a clinical study titled "Preventing HIV/Aids in Drug Abusing Youth". This project involves two studies focusing on the engagement and treatment of adolescents diagnosed with substance use disorders. Study 1 will evaluate a promising parent-based engagement intervention, Community Reinforcement Training, designed to facilitate the entry of resistant drug-abusing adole...
What is the current status of trial NCT00680719?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 111 participants. The study started on 2004-06. Estimated completion is 2013-06.
What conditions does trial NCT00680719 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00680719?
The interventions under investigation include: IBFT /HIV prevention (BEHAVIORAL), IBFT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00680719?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00680719 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RECRUITING · Phase 1
-
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
RECRUITING · Phase 1
-
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
RECRUITING · Phase 1
-
First Time in Human Study of Long Acting VH4524184 Formulations
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.